Side-by-side comparison of AI visibility scores, market position, and capabilities
Global ag processing giant with $85.5B FY2024 revenue; 2024 SEC/accounting scandal triggered CEO leave and stock -30%; core grain trading/oilseed crushing remains strong; NYSE: ADM.
Archer-Daniels-Midland Company (ADM) is one of the world's largest agricultural processors and food ingredient companies, founded in 1902 in Chicago, Illinois where it remains headquartered, trading on NYSE (ADM). The company generated approximately $85.5 billion in revenues for FY2024, operating across three segments: Ag Services & Oilseeds (grain origination, oilseed crushing, biodiesel), Carbohydrate Solutions (corn wet milling, ethanol, sweeteners), and Nutrition (animal nutrition, human nutrition ingredients including proteins and flavors). ADM's global grain trading and origination network—spanning elevator assets, river barges, export terminals, and trading desks—positions it as critical infrastructure in global food supply chains connecting North American and South American farmers to end users across Asia, Europe, and the Middle East.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.